Selected research
Market Structure
Global Transthyretin (TTR) Modulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Transthyretin (TTR) Modulators market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Transthyretin (TTR) Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Transthyretin (TTR) Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Transthyretin (TTR) Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Transthyretin (TTR) Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Transthyretin (TTR) Modulators include AstraZeneca AB, BridgeBio Pharma, Inc, Medison Pharma Australia Pty Ltd and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Transthyretin (TTR) Modulators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Transthyretin (TTR) Modulators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Transthyretin (TTR) Modulators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transthyretin (TTR) Modulators market size, projected growth trends, production technologies, key applications, and end-use industries.
Transthyretin (TTR) Modulators Segment by Company
AstraZeneca AB
BridgeBio Pharma, Inc
Medison Pharma Australia Pty Ltd
Pfizer Inc
Transthyretin (TTR) Modulators Segment by Type
Small Interfering RNA
Small Molecule Drugs
Transthyretin (TTR) Modulators Segment by Application
Hospital
Clinic
Others
Transthyretin (TTR) Modulators Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transthyretin (TTR) Modulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transthyretin (TTR) Modulators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transthyretin (TTR) Modulators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Transthyretin (TTR) Modulators market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transthyretin (TTR) Modulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transthyretin (TTR) Modulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Transthyretin (TTR) Modulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Small Interfering RNA
- Small Molecule Drugs
Applications
- Hospital
- Clinic
- Others
Companies covered
- AstraZeneca AB
- BridgeBio Pharma, Inc
- Medison Pharma Australia Pty Ltd
- Pfizer Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Transthyretin (TTR) Modulators Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Transthyretin (TTR) Modulators Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Transthyretin (TTR) Modulators Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Transthyretin (TTR) Modulators Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Transthyretin (TTR) Modulators Market Dynamics
- 2.1 Transthyretin (TTR) Modulators Industry Trends
- 2.2 Transthyretin (TTR) Modulators Industry Drivers
- 2.3 Transthyretin (TTR) Modulators Industry Opportunities and Challenges
- 2.4 Transthyretin (TTR) Modulators Industry Restraints
3 Transthyretin (TTR) Modulators Market by Manufacturers
- 3.1 Global Transthyretin (TTR) Modulators Revenue by Manufacturers (2021-2026)
- 3.2 Global Transthyretin (TTR) Modulators Sales by Manufacturers (2021-2026)
- 3.3 Global Transthyretin (TTR) Modulators Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Transthyretin (TTR) Modulators Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Transthyretin (TTR) Modulators Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Transthyretin (TTR) Modulators Manufacturers, Product Type & Application
- 3.7 Global Transthyretin (TTR) Modulators Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Transthyretin (TTR) Modulators Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Transthyretin (TTR) Modulators Players Market Share by Revenue in 2025
- 3.8.3 2025 Transthyretin (TTR) Modulators Tier 1, Tier 2, and Tier 3
4 Transthyretin (TTR) Modulators Market by Type
- 4.1 Transthyretin (TTR) Modulators Type Introduction
- 4.1.1 Small Interfering RNA
- 4.1.2 Small Molecule Drugs
- 4.2 Global Transthyretin (TTR) Modulators Sales by Type
- 4.2.1 Global Transthyretin (TTR) Modulators Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Transthyretin (TTR) Modulators Sales by Type (2021-2032)
- 4.2.3 Global Transthyretin (TTR) Modulators Sales Market Share by Type (2021-2032)
- 4.3 Global Transthyretin (TTR) Modulators Revenue by Type
- 4.3.1 Global Transthyretin (TTR) Modulators Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Transthyretin (TTR) Modulators Revenue by Type (2021-2032)
- 4.3.3 Global Transthyretin (TTR) Modulators Revenue Market Share by Type (2021-2032)
5 Transthyretin (TTR) Modulators Market by Application
- 5.1 Transthyretin (TTR) Modulators Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Transthyretin (TTR) Modulators Sales by Application
- 5.2.1 Global Transthyretin (TTR) Modulators Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Transthyretin (TTR) Modulators Sales by Application (2021-2032)
- 5.2.3 Global Transthyretin (TTR) Modulators Sales Market Share by Application (2021-2032)
- 5.3 Global Transthyretin (TTR) Modulators Revenue by Application
- 5.3.1 Global Transthyretin (TTR) Modulators Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Transthyretin (TTR) Modulators Revenue by Application (2021-2032)
- 5.3.3 Global Transthyretin (TTR) Modulators Revenue Market Share by Application (2021-2032)
6 Global Transthyretin (TTR) Modulators Sales by Region
- 6.1 Global Transthyretin (TTR) Modulators Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Transthyretin (TTR) Modulators Sales by Region (2021-2032)
- 6.2.1 Global Transthyretin (TTR) Modulators Sales by Region (2021-2026)
- 6.2.2 Global Transthyretin (TTR) Modulators Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Transthyretin (TTR) Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Transthyretin (TTR) Modulators Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Transthyretin (TTR) Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Transthyretin (TTR) Modulators Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Transthyretin (TTR) Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Transthyretin (TTR) Modulators Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Transthyretin (TTR) Modulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Transthyretin (TTR) Modulators Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Transthyretin (TTR) Modulators Revenue by Region
- 7.1 Global Transthyretin (TTR) Modulators Revenue by Region
- 7.1.1 Global Transthyretin (TTR) Modulators Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Transthyretin (TTR) Modulators Revenue by Region (2021-2026)
- 7.1.3 Global Transthyretin (TTR) Modulators Revenue by Region (2027-2032)
- 7.1.4 Global Transthyretin (TTR) Modulators Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Transthyretin (TTR) Modulators Revenue (2021-2032)
- 7.2.2 North America Transthyretin (TTR) Modulators Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Transthyretin (TTR) Modulators Revenue (2021-2032)
- 7.3.2 Europe Transthyretin (TTR) Modulators Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Transthyretin (TTR) Modulators Revenue (2021-2032)
- 7.4.2 Asia-Pacific Transthyretin (TTR) Modulators Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Transthyretin (TTR) Modulators Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Transthyretin (TTR) Modulators Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 AstraZeneca AB
- 8.1.1 AstraZeneca AB Company Information
- 8.1.2 AstraZeneca AB Business Overview
- 8.1.3 AstraZeneca AB Transthyretin (TTR) Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 AstraZeneca AB Transthyretin (TTR) Modulators Product Portfolio
- 8.1.5 AstraZeneca AB Recent Developments
- 8.2 BridgeBio Pharma, Inc
- 8.2.1 BridgeBio Pharma, Inc Company Information
- 8.2.2 BridgeBio Pharma, Inc Business Overview
- 8.2.3 BridgeBio Pharma, Inc Transthyretin (TTR) Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 BridgeBio Pharma, Inc Transthyretin (TTR) Modulators Product Portfolio
- 8.2.5 BridgeBio Pharma, Inc Recent Developments
- 8.3 Medison Pharma Australia Pty Ltd
- 8.3.1 Medison Pharma Australia Pty Ltd Company Information
- 8.3.2 Medison Pharma Australia Pty Ltd Business Overview
- 8.3.3 Medison Pharma Australia Pty Ltd Transthyretin (TTR) Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Medison Pharma Australia Pty Ltd Transthyretin (TTR) Modulators Product Portfolio
- 8.3.5 Medison Pharma Australia Pty Ltd Recent Developments
- 8.4 Pfizer Inc
- 8.4.1 Pfizer Inc Company Information
- 8.4.2 Pfizer Inc Business Overview
- 8.4.3 Pfizer Inc Transthyretin (TTR) Modulators Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Pfizer Inc Transthyretin (TTR) Modulators Product Portfolio
- 8.4.5 Pfizer Inc Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Transthyretin (TTR) Modulators Value Chain Analysis
- 9.1.1 Transthyretin (TTR) Modulators Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Transthyretin (TTR) Modulators Production Mode & Process
- 9.2 Transthyretin (TTR) Modulators Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Transthyretin (TTR) Modulators Distributors
- 9.2.3 Transthyretin (TTR) Modulators Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst